Altered GABA transmission in a mouse model of increased trait anxiety

Neuroscience

Volumn 183, Issue , 2011, Pages 71-80

  Tasan, R O ^a   Bukovac, A ^a   Peterschmitt, Y N ^a,b   Sartori, S B ^a   Landgraf, R ^c   Singewald, N ^a   Sperk, G ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Amygdala; FosB; GABAA receptor; Glutamate decarboxylase; HAB; High anxiety related behavior

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA2; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA3; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA4; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA5; 4 AMINOBUTYRIC ACID A RECEPTOR BETA1; 4 AMINOBUTYRIC ACID A RECEPTOR BETA2; 4 AMINOBUTYRIC ACID A RECEPTOR BETA3; 4 AMINOBUTYRIC ACID A RECEPTOR GAMMA1; 4 AMINOBUTYRIC ACID A RECEPTOR GAMMA2; 4 AMINOBUTYRIC ACID C RECEPTOR 1; 4 AMINOBUTYRIC ACID C RECEPTOR 2; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; MESSENGER RNA; TRANSCRIPTION FACTOR FOSB; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; BASOLATERAL AMYGDALA; CENTRAL NUCLEUS (AMYGDALA); CONTROLLED STUDY; GABAERGIC TRANSMISSION; GENE EXPRESSION; HISTOCHEMISTRY; IMMUNOREACTIVITY; LOCOMOTION; MALE; MEDIAL AMYGDALA; MOTOR ACTIVITY; MOUSE; NEUROTRANSMISSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMYGDALA; ANALYSIS OF VARIANCE; ANIMALS; ANXIETY; DISEASE MODELS, ANIMAL; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION REGULATION; GLUTAMATE DECARBOXYLASE; MALE; MAZE LEARNING; MICE; PROTEIN SUBUNITS; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, GABA-A; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; SYNAPTIC TRANSMISSION;

EID: 79955609669     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.03.051     Document Type: Article

References (55)

1. Andlin-Sobocki P., Jonsson B., Wittchen H.U., Olesen J. Cost of disorders of the brain in Europe. Eur J Neurol 2005, 12(Suppl 1):1-27.
2. Belzung C., Griebel G. Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav Brain Res 2001, 125:141-149.
3. Bert B., Fink H., Sohr R., Rex A. Different effects of diazepam in Fischer rats and two stocks of Wistar rats in tests of anxiety. Pharmacol Biochem Behav 2001, 70:411-420.
4. Bourgeais L., Gauriau C., Bernard J.F. Projections from the nociceptive area of the central nucleus of the amygdala to the forebrain: a PHA-L study in the rat. Eur J Neurosci 2001, 14:229-255.
5. Carta A.R., Moreno C.C., Cadoni C., Tronci E., Di Chiara G. Long-term increase in GAD67 mRNA expression in the central amygdala of rats sensitized by drugs and stress. Eur J Neurosci 2008, 27:1220-1230.
6. Chacur C., Raymond R., Hipolide D.C., Giugliano E.B., Leite J.R., Nobrega J.N. Immediate increase in benzodiazepine binding in rat brain after a single brief experience in the plus maze: a paradoxical effect. Neurosci Lett 1999, 269:29-32.
7. Crestani F., Keist R., Fritschy J.M., Benke D., Vogt K., Prut L., Bluthmann H., Mohler H., Rudolph U. Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors. Proc Natl Acad Sci U S A 2002, 99:8980-8985.
8. Crestani F., Lorez M., Baer K., Essrich C., Benke D., Laurent J.P., Belzung C., Fritschy J.M., Luscher B., Mohler H. Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues. Nat Neurosci 1999, 2:833-839.
9. Davis M., Rainnie D., Cassell M. Neurotransmission in the rat amygdala related to fear and anxiety. Trends Neurosci 1994, 17:208-214.
10. Esmaeili A., Lynch J.W., Sah P. GABAA receptors containing gamma1 subunits contribute to inhibitory transmission in the central amygdala. J Neurophysiol 2009, 101:341-349.
11. Franklin KBJ, Paxinos G (2007) The mouse brain in stereotaxic coordinates, 3rd edition. London: Elsevier.
12. Furtinger S., Pirker S., Czech T., Baumgartner C., Ransmayr G., Sperk G. Plasticity of Y1 and Y2 receptors and neuropeptide Y fibers in patients with temporal lobe epilepsy. J Neurosci 2001, 21:5804-5812.
13. Hasler G., Nugent A.C., Carlson P.J., Carson R.E., Geraci M., Drevets W.C. Altered cerebral gamma-aminobutyric acid type A-benzodiazepine receptor binding in panic disorder determined by [11C]flumazenil positron emission tomography. Arch Gen Psychiatry 2008, 65:1166-1175.
14. Heldt S.A., Ressler K.J. Training-induced changes in the expression of GABAA-associated genes in the amygdala after the acquisition and extinction of Pavlovian fear. Eur J Neurosci 2007, 26:3631-3644.
15. Heldt S.A., Ressler K.J. Forebrain and midbrain distribution of major benzodiazepine-sensitive GABAA receptor subunits in the adult C57 mouse as assessed with in situ hybridization. Neuroscience 2007, 150:370-385.
16. Hettema J.M., An S.S., Neale M.C., Bukszar J., van den Oord E.J., Kendler K.S., Chen X. Association between glutamic acid decarboxylase genes and anxiety disorders, major depression, and neuroticism. Mol Psychiatry 2006, 11:752-762.
17. Hoffman G.E., Lyo D. Anatomical markers of activity in neuroendocrine systems: are we all "fos-ed out"?. J Neuroendocrinol 2002, 14:259-268.
18. Kash S.F., Tecott L.H., Hodge C., Baekkeskov S. Increased anxiety and altered responses to anxiolytics in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci U S A 1999, 96:1698-1703.
19. Kovacs K.J. Measurement of immediate-early gene activation- c-fos and beyond. J Neuroendocrinol 2008, 20:665-672.
20. Kromer S.A., Kessler M.S., Milfay D., Birg I.N., Bunck M., Czibere L., Panhuysen M., Putz B., Deussing J.M., Holsboer F., Landgraf R., Turck C.W. Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety. J Neurosci 2005, 25:4375-4384.
21. LeDoux J.E., Iwata J., Cicchetti P., Reis D.J. Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J Neurosci 1988, 8:2517-2529.
22. Liebsch G., Linthorst A.C., Neumann I.D., Reul J.M., Holsboer F., Landgraf R. Behavioral, physiological, and neuroendocrine stress responses and differential sensitivity to diazepam in two Wistar rat lines selectively bred for high- and low-anxiety-related behavior. Neuropsychopharmacology 1998, 19:381-396.
23. Likhtik E., Popa D., Apergis-Schoute J., Fidacaro G.A., Pare D. Amygdala intercalated neurons are required for expression of fear extinction. Nature 2008, 454:642-645.
24. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl) 1987, 92:180-185.
25. Low K., Crestani F., Keist R., Benke D., Brunig I., Benson J.A., Fritschy J.M., Rulicke T., Bluethmann H., Mohler H., Rudolph U. Molecular and neuronal substrate for the selective attenuation of anxiety. Science 2000, 290:131-134.
26. McDonald A.J., Mascagni F. Neuronal localization of m1 muscarinic receptor immunoreactivity in the rat basolateral amygdala. Brain Struct Funct 2010, 215:37-48.
27. McDonald A.J., Pearson J.C. Coexistence of GABA and peptide immunoreactivity in non-pyramidal neurons of the basolateral amygdala. Neurosci Lett 1989, 100:53-58.
28. Millan M.J. The neurobiology and control of anxious states. Prog Neurobiol 2003, 70:83-244.
29. Mombereau C., Kaupmann K., Froestl W., Sansig G., van der Putten H., Cryan J.F. Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety- and antidepressant-like behavior. Neuropsychopharmacology 2004, 29:1050-1062.
30. Mombereau C., Kaupmann K., Gassmann M., Bettler B., van der Putten H., Cryan J.F. Altered anxiety and depression-related behaviour in mice lacking GABAB(2) receptor subunits. Neuroreport 2005, 16:307-310.
31. Morris H.V., Dawson G.R., Reynolds D.S., Atack J.R., Stephens D.N. Both alpha2 and alpha3 GABAA receptor subtypes mediate the anxiolytic properties of benzodiazepine site ligands in the conditioned emotional response paradigm. Eur J Neurosci 2006, 23:2495-2504.
32. Muigg P., Hetzenauer A., Hauer G., Hauschild M., Gaburro S., Frank E., Landgraf R., Singewald N. Impaired extinction of learned fear in rats selectively bred for high anxiety-evidence of altered neuronal processing in prefrontal-amygdala pathways. Eur J Neurosci 2008, 28:2299-2309.
33. Muigg P., Scheiber S., Salchner P., Bunck M., Landgraf R., Singewald N. Differential stress-induced neuronal activation patterns in mouse lines selectively bred for high, normal or low anxiety. PLoS One 2009, 4:e5346.
34. Nelovkov A., Areda T., Innos J., Koks S., Vasar E. Rats displaying distinct exploratory activity also have different expression patterns of gamma-aminobutyric acid- and cholecystokinin-related genes in brain regions. Brain Res 2006, 1100:21-31.
35. Nemeroff C.B. The role of GABA in the pathophysiology and treatment of anxiety disorders. Psychopharmacol Bull 2003, 37:133-146.
36. Nishimura T., Schwarzer C., Gasser E., Kato N., Vezzani A., Sperk G. Altered expression of GABA(A) and GABA(B) receptor subunit mRNAs in the hippocampus after kindling and electrically induced status epilepticus. Neuroscience 2005, 134:691-704.
37. Norrholm S.D., Ressler K.J. Genetics of anxiety and trauma-related disorders. Neuroscience 2009, 164:272-287.
38. Olsen R.W., Sieghart W. GABA A receptors: subtypes provide diversity of function and pharmacology. Neuropharmacology 2009, 56:141-148.
39. Pare D., Royer S., Smith Y., Lang E.J. Contextual inhibitory gating of impulse traffic in the intra-amygdaloid network. Ann N Y Acad Sci 2003, 985:78-91.
40. Pirker S., Schwarzer C., Czech T., Baumgartner C., Pockberger H., Maier H., Hauer B., Sieghart W., Furtinger S., Sperk G. Increased expression of GABA(A) receptor beta-subunits in the hippocampus of patients with temporal lobe epilepsy. J Neuropathol Exp Neurol 2003, 62:820-834.
41. Quirk G.J., Gehlert D.R. Inhibition of the amygdala: key to pathological states?. Ann N Y Acad Sci 2003, 985:263-272.
42. Sajdyk T.J., Shekhar A. Sodium lactate elicits anxiety in rats after repeated GABA receptor blockade in the basolateral amygdala. Eur J Pharmacol 2000, 394:265-273.
43. Scimemi A., Semyanov A., Sperk G., Kullmann D.M., Walker M.C. Multiple and plastic receptors mediate tonic GABAA receptor currents in the hippocampus. J Neurosci 2005, 25:10016-10024.
44. Semyanov A., Walker M.C., Kullmann D.M. GABA uptake regulates cortical excitability via cell type-specific tonic inhibition. Nat Neurosci 2003, 6:484-490.
45. Semyanov A., Walker M.C., Kullmann D.M., Silver R.A. Tonically active GABA A receptors: modulating gain and maintaining the tone. Trends Neurosci 2004, 27:262-269.
46. Shekhar A., Sajdyk T.J., Gehlert D.R., Rainnie D.G. The amygdala, panic disorder, and cardiovascular responses. Ann N Y Acad Sci 2003, 985:308-325.
47. Shen Q., Lal R., Luellen B.A., Earnheart J.C., Andrews A.M., Luscher B. gamma-Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression. Biol Psychiatry 2010, 68:512-520.
48. Sieghart W., Sperk G. Subunit composition, distribution and function of GABA(A) receptor subtypes. Curr Top Med Chem 2002, 2:795-816.
49. Singewald N. Altered brain activity processing in high-anxiety rodents revealed by challenge paradigms and functional mapping. Neurosci Biobehav Rev 2007, 31:18-40.
50. Tasan R.O., Nguyen N.K., Weger S., Sartori S.B., Singewald N., Heilbronn R., Herzog H., Sperk G. The central and basolateral amygdala are critical sites of neuropeptide Y/Y2 receptor-mediated regulation of anxiety and depression. J Neurosci 2010, 30:6282-6290.
51. Tschenett A., Singewald N., Carli M., Balducci C., Salchner P., Vezzani A., Herzog H., Sperk G. Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors. Eur J Neurosci 2003, 18:143-148.
52. Tsunashima K., Schwarzer C., Kirchmair E., Sieghart W., Sperk G. GABA(A) receptor subunits in the rat hippocampus III: altered messenger RNA expression in kainic acid-induced epilepsy. Neuroscience 1997, 80:1019-1032.
53. Ulrich D., Bettler B. GABA(B) receptors: synaptic functions and mechanisms of diversity. Curr Opin Neurobiol 2007, 17:298-303.
54. Woodruff A.R., Monyer H., Sah P. GABAergic excitation in the basolateral amygdala. J Neurosci 2006, 26:11881-11887.
55. Zarnowska E.D., Keist R., Rudolph U., Pearce R.A. GABAA receptor alpha5 subunits contribute to GABAA, slow synaptic inhibition in mouse hippocampus. J Neurophysiol 2009, 101:1179-1191.